About Ian Silverman
Form D filings for Revere Pharmaceuticals from 2019 to 2023 list Ian Silverman as president and chief executive officer, director.
Ian Silverman first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Ian Silverman in the role, so the role may have started earlier or lasted longer.
Revere Pharmaceuticals Inc.
President and Chief Executive Officer, director
2019 – 2023 · Arlington, MA
Key Colleagues at Startups
The people Ian Silverman works with at each company, as listed on that company's latest Form D.
Revere Pharmaceuticals Inc. · Form D, Jun 12, 2023